Vaccine adverse event reporting system reporting source: A possible source of bias in longitudinal studies

Pediatrics

Volumn 117, Issue 2, 2006, Pages 387-390

  Goodman, Michael J ^a   Nordin, James ^a  

^a HEALTHPARTNERS RESEARCH FOUNDATION   (United States)

Author keywords

Adverse event reporting systems; VAERS

Indexed keywords

LYME DISEASE VACCINE; THIOMERSAL; VACCINE;

ALGORITHM; ARTHRALGIA; ARTICLE; AUTISM; DRUG OVERDOSE; HEALTH CARE SYSTEM; HUMAN; LAW SUIT; LONGITUDINAL STUDY; MENTAL DEFICIENCY; NEUROPATHY; PRIORITY JOURNAL; SPEECH DISORDER; UNSPECIFIED SIDE EFFECT; DRUG SURVEILLANCE PROGRAM; EPIDEMIOLOGY; LEGAL ASPECT; LEGAL LIABILITY; UNITED STATES; UTILIZATION REVIEW; VACCINATION;

ADVERSE DRUG REACTION REPORTING SYSTEMS; BIAS (EPIDEMIOLOGY); HUMANS; LIABILITY, LEGAL; LONGITUDINAL STUDIES; UNITED STATES; VACCINATION; VACCINES;

EID: 33644854456     PISSN: 00314005     EISSN: 02105721     Source Type: Journal    
DOI: 10.1542/peds.2004-2687     Document Type: Article

References (14)

1. Braun MM, Mootrey GT, Salive ME, Chen RT, Ellenberg SS. Infant immunization with acellular pertussis vaccines in the United States: assessment of the first two years' data from the Vaccine Adverse Event Reporting System (VAERS). Pediatrics. 2000;106(4). Available at: www.pediatrics.org/cgi/ content/full/106/4/e51
2. Chen RT, Rastogi SC, Mullen JR, et al. The Vaccine Adverse Event Reporting System (VAERS). Vaccine. 1994;12:542-550
3. Ellenberg SS, Braun MM. Monitoring the safety of vaccines: assessing the risks. Drug Saf. 2002;25:145-152
4. Niu MT, Erwin DE, Braun MM. Data mining in the US Vaccine Adverse Event Reporting System (VAERS): early detection of intussusception and other events after rotavirus vaccination. Vaccine. 2001;19:4627-4634
5. Singleton JA, Lloyd JC, Mootrey GT, Salive ME, Chen RT. An overview of the vaccine adverse event reporting system (VAERS) as a surveillance system. VAERS Working Group. Vaccine. 1999;17:2908-2917
6. Varricchio F, Iskander J, Destefano F, et al. Understanding vaccine safety information from the Vaccine Adverse Event Reporting System. Pediatr Infect Dis J. 2004;23:287-294
7. Zhou W, Pool V, Iskander JK, et al. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS) - United States, 1991-2001. MMWR Surveill Summ. 2003;52:1-24
8. Woo EJ, Ball R, Bostrom A, et al. Vaccine risk perception among reporters of autism after vaccination: Vaccine Adverse Event Reporting System 1990-2001. Am J Public Health. 2004;94:990-995
9. Wakefield AJ, Murch SH, Anthony A, et al. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet. 1998;351:637-641
10. Thimerosal in vaccines: a joint statement of the American Academy of Pediatrics and the Public Health Service. MMWR Morb Mortal Wkly Rep. 1999;48:563-565
11. Geier DA, Geier MR. An assessment of the impact of thimerosal on childhood neurodevelopmental disorders. Pediatr Rehabil. 2003;6:97-102
12. Geier DA, Geier MR. A comparative evaluation of the effects of MMR immunization and mercury doses from thimerosal-containing childhood vaccines on the population prevalence of autism. Med Sci Monit. 2004;10:PI33-PI39
13. Geier MR, Geier DA. Thimerosal in childhood vaccines, neurodevelopment disorders, and heart disease in the united states. J Am Physicians Surg. 2003;8:6-11
14. Geier MR, Geier DA. Neurodevelopmental disorders after thimerosal-containing vaccines: a brief communication. Exp Biol Med (Maywood). 2003;228:660-664